Payers
Medicaid spending on GLP-1s has skyrocketed since 2019, study finds
Spending rose more than 500% in the last five years, KFF researchers found.
Weight Loss
Pharma
Study: 16 new obesity drugs could come to market in the next 5 years
The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
Startups
Weight-inclusive primary care founder shares what good healthcare looks like amid GLP-1 craze
Giving patients a “healthcare home” is the best care for weight management, according to one startup founder.
Startups
Why some startups and VC firms are betting on in-person healthcare
While there’s been a push toward virtual care, two startup founders still see in-person experiences as valuable.
Pharma
GLP-1s could become Medicare’s most expensive drugs
Even conservative estimates say Medicare could spend an additional $34+ billion a year due to the drugs.
Pharma
Eli Lilly selling discounted, single-dose vials of blockbuster GLP-1 drug Zepbound
The drugmaker said it hopes the move will ease supply constraints and increase patient access.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
